MediciNova (MNOV) Stock Highlights

1.95 | +2.63%

2024-11-21 06:02:30

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firms current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases. It has the acquisition and development of the small molecule therapeutics segments.

Statistics

Range Today

1.82 1.97

Volume Today 59.9K

Range 1 Year

1.12 2.55

Volume 1 Year 17.13M

Range 3 Year

1.12 4.65

Volume 3 Year 67.09M

Range 10 Year

1.12 14.5

Volume 10 Year 502.66M

Highlights

Market Capitalization 75.04M (small)

Floating Shares 42.08M

Current Price 1.95

Price To Earnings -9.69

Price To Revenue 31.2

Price To Book 1.31

Earnings Per Share -0.16

Payout Ratio 0%

Performance

Latest +2.63%

1 Month +7.73%

3 Months +66.67%

6 Months +37.32%

1 Year -2.01%

3 Years -39.44%

5 Years -75.93%

10 Years -34.56%

Benchmarks

Market Capitalization

285 / 368

Gross Profits

0 / 278

Total Revenue

236 / 300

Total Rank

192 / 368

Free Cashflow

82 / 352

Performance 5 years

223 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.